We demonstrate the potential utility of DCE-MRI derived pharmacokinetic parameters in differentiating brain tumour types using the extended Tofts and the Shutter Speed Model. Results show an increasing pattern in Ktrans, ve, vp estimates in GBM and metastasis compared to primary central nervous system lymphoma (PCNSL). The τi estimate in GBM was the lowest, while it was highest in PCNSL.
This abstract and the presentation materials are available to members only; a login is required.